Exact Sciences Corporation - Common Stock (NQ:EXAS)

104.91 UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

23 24 Next >

Exact Sciences Announces Fourth Quarter 2024 Results

February 19, 2025

From Exact Sciences Corp.

Via Business Wire

Trump Calls For More Tariffs, Federal Reserve Minutes On Deck: What's Driving Markets Wednesday? ↗

February 19, 2025

All three major U.S. indices are red in Wednesday's midday trading as investors weighed President Donald Trump's proposed tariffs on auto imports, pharmaceuticals and semiconductors.

Via Benzinga

Earnings Scheduled For February 19, 2025 ↗

February 19, 2025

Via Benzinga

Exact Sciences (EXAS) Reports Earnings Tomorrow: What To Expect

February 18, 2025

Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) will be announcing earnings results tomorrow after market close. Here’s what to look for.

Via StockStory

Forecasting The Future: 19 Analyst Projections For Exact Sciences ↗

January 23, 2025

Via Benzinga

(EXAS) - Analyzing Exact Sciences's Short Interest ↗

December 31, 2024

Via Benzinga

What 19 Analyst Ratings Have To Say About Exact Sciences ↗

November 26, 2024

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

February 14, 2025

Via Benzinga

Exact Sciences Schedules Fourth Quarter 2024 Earnings Call

February 03, 2025

From Exact Sciences Corp.

Via Business Wire

Exact Sciences Demonstrates Leadership in Cancer Innovation with New Data on Screening and Molecular Residual Disease at 2025 ASCO GI Symposium

January 21, 2025

From Exact Sciences Corp.

Via Business Wire

New Evidence Validates Oncodetect's™ Ability to Detect Molecular Residual Disease and Predict Recurrence in Colorectal Cancer Patients

January 21, 2025

From Exact Sciences Corp.

Via Business Wire

Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone ↗

January 21, 2025

The company is working to expand the uses and reimbursement for its blood-based tests for cancer.

Via Investor's Business Daily

Exact Sciences Stock Drops 12% Over Four Days. 'What Is Going On?' ↗

January 16, 2025

The company is facing numerous headline risks. But not all of them are legitimate, says one analyst.

Via Investor's Business Daily

2 Healthcare Stocks to Buy Hand Over Fist in January ↗

January 16, 2025

Via The Motley Fool

Exact Sciences Sparks Analyst Optimism Amid Competitive Multi-Cancer Test Market ↗

January 13, 2025

Exact Sciences' 2024 sales grew 10% to $2.76 billion, exceeding estimates. New cancer tests, including Cologuard Plus, are set for 2025 launch.

Via Benzinga

Exact Sciences Announces Preliminary Fourth Quarter 2024 Results

January 12, 2025

From Exact Sciences Corp.

Via Business Wire

Exact Sciences to Participate in J.P. Morgan Healthcare Conference

January 02, 2025

From Exact Sciences Corp.

Via Business Wire

Rivian Automotive, Rocket Lab And Moderna Are Among Top 10 Large-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio? ↗

December 01, 2024

Top performers last week: RIVN, RKLB, SRPT, EXAS, ESTC, ULTA, MRNA, RL, CPRT, SNAP. Any in your portfolio? Citigroup raises price target on ULTA and SNAP.

Via Benzinga

Why Is Exact Sciences Stock Trading Higher On Monday? ↗

November 26, 2024

Centers for Medicare & Medicaid Services finalizes 2025 pricing for Exact Sciences' Cologuard Plus, raising Medicare reimbursement by 16% and boosting growth projections for next year.

Via Benzinga

J.M. Smucker Posts Upbeat Earnings, Joins LexinFintech, Semtech, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday ↗

November 26, 2024

Via Benzinga

US Stocks May Have A Slow Start As Trump's Tariff Threat Begins To Thwart Relief Rally: Analysts Remain Optimistic About AI-Linked Sectors Stocks ↗

November 26, 2024

U.S. stocks could open on a sluggish note on Tuesday after ending in green on Monday as President-elect Donald Trump threatened to hit two of U.S.'s largest trading partners - Canada and Mexico - with...

Via Benzinga

Topics Government

Exact Sciences to Participate in December Investor Conferences

November 26, 2024

From Exact Sciences Corp.

Via Business Wire

Exact Sciences Advances Breast Cancer Care with the Oncotype DX® test and Genomic Profiling Research at SABCS 2024

November 25, 2024

From Exact Sciences Corp.

Via Business Wire

Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy

November 13, 2024

From Exact Sciences Corp.

Via Business Wire

Exact Sciences Collapses On 'Alarming' Guidance Cut. Is The Growth Story Broken? ↗

November 06, 2024

The company reported lighter-than-expected third-quarter sales due to issues with physician order rates.

Via Investor's Business Daily

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 06, 2024

Via Benzinga

Colorectal Cancer Diagnostic Focused Exact Sciences Stock Plunges On Weak Annual Guidance, Analyst Sees Compelling Long-Term Entry Point ↗

November 06, 2024

Exact Sciences Q3 EPS loss of $0.21 fell short of analyst expectations. 2024 revenue guidance lowered amid screening segment hurdles, growth plans set for 2025.

Via Benzinga

Exact Sciences Posts Downbeat Results, Joins Super Micro Computer, Honda Motor And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

November 06, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 06, 2024

Via Benzinga

Why Tesla Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗

November 06, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.